Apnimed, Inc. Common Stock

APMDNASDAQUSD
27.37 USD
1.74 (6.79%)AT CLOSE (11:59 AM EDT)
27.30
0.07 (0.27%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
27.30
0.07 (0.27%)
🟢Market: OPEN

Apnimed, Inc. Common Stock (APMD) trades at $27.30 per share. Technical indicators currently signal "Sell". This is driven by a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Aug 25, 2026.

Open?$26.60
High?$29.56
Low?$26.01
Prev. Close?$25.63
Volume?480.6K
Avg. Volume?N/A
VWAP?$27.38
Bid / Ask
Bid?$22.01 × 100
Ask?$38.66 × 100
Spread?$16.65
Midpoint?$30.34
Valuation & Ratios
Market Cap?1.0B
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Employees
N/A
Market Cap
1.0B
Industry
N/A
Listed
2026-07-31
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short Interest?407.6K
Days to Cover?1.0
Avg Daily Volume411.5K
Settlement Date2026-08-14